Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Drug Pipeline Progress – December 29-31

By Drug Discovery Trends Editor | January 9, 2009

EMBEDA (morphine sulfate and naltrexone hydrochloride)
Company: King Pharmaceuticals, Inc. 
FDA is continuing its review of the New Drug Application (NDA) for EMBEDA (morphine sulfate and naltrexone hydrochloride) extended release capsules, December 31, 2008
Company Comments: King Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) is continuing its review of the New Drug Application (NDA) for EMBEDA (morphine sulfate and naltrexone hydrochloride) extended release capsules. It is likely that this review will extend into early 2009.

Nicotine Polacrilex Gum USP
Company: Watson Pharmaceuticals 
Received FDA Approval for Mint Coated Nicotine Gum, December 31, 2008
Company Comments: Watson Pharmaceuticals has received approval from the United States Food and Drug Administration to market its over-the-counter Nicotine Polacrilex Gum USP, coated mint flavor, in the 2 mg and 4 mg strengths.

Stavudine Capsules
Company: Mylan Inc.
Received Final FDA Approval for the Generic Version of the Antiretroviral Stavudine Capsules, December 29, 2008
Company Comments: Mylan Inc. received final approval from the U.S. Food and Drug Administration (FDA) on December 29, for its Abbreviated New Drug Application (ANDA) for Stavudine Capsules USP, 15 mg, 20mg, 30 mg, and 40 mg.

Mircette
Company: Watson Pharmaceuticals 
Received FDA Final Approval for Generic Mircette, December 29, 2008
Company Comments: Watson Pharmaceuticals has received final approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for desogestrel/ethinyl estradiol and ethinyl estradiol tablets USP, 0.15 mg / 0.02 mg.

balsalazide
Company: Salix Pharmaceuticals, Ltd. 
Received FDA Complete Response Letter for balsalazide tablet, December 29, 2008
Company Comments: Based on its review, the FDA has determined that the application cannot be approved in its present form and that clinical data from an additional adequate and well-controlled clinical trial will be required in order to conduct further review on the NDA.

Ibuprofen PM
Company: Perrigo Company 
Announced FDA Final Approval for Ibuprofen PM, December 29, 2008
Company Comments: Perrigo Company announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Ibuprofen and Diphenhydramine Citrate Tablets, 200/38 mg.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50